| VUTRISIRAN | Alnylam Pharms INC | ||
| 25MG/0.5ML ; Subcutaneous Solution |
Less Than $1000 mn
|
||
| None | None | ||
|
Less Than 5
|
None | ||
| None | None | ||
| AMVUTTRA is a transthyretin-directed small interfering RNA indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. | |||
|
Yes
| |||
| AMVUTTRA | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||
| *************** ** *** ************ ****** | ************ ********** ** ******** ****** *** **************** | ************ ********** ** ******** ****** *** **************** | ************ ********** ** ******** ****** *** **************** | ************ ********** ** ******** ****** *** **************** | **** ******, ************ *** ******* ** *** ******* *** ******** ************* (***) ********** ******** | **** ******, ************ *** ******* ** *** ******* *** ******** ************* (***) ********** ******** | ******** ******-******** *** ****** | ******** ******-******** *** ****** | ************* (***) **** ************ *** ******* ** *** ******* *** ******** ** ********** ***-********** ******** | ************* (***) **** ************ *** ******* ** *** ******* *** ******** ** ********** ***-********** ******** | ************* (***) **** ************ *** ******* ** *** ******* *** ******** ** ********** ***-********** ******** | ************* (***) **** ************ *** ******* ** *** ******* *** ******** ** ********** ***-********** ******** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|